Indeed, several clinical trials and meta-analyses[16–21] for GLP-1 RAs have demonstrated the lowering effect of glycemic levels as well as raised hypoglycemia and treatment discontinuation, although the mechanisms are not very clearly understood. Here, GLP1R is linked to Hypoglycemia.